Cargando…
Butorphanol Inhibits the Malignant Biological Behaviors of Ovarian Cancer Cells via Down-Regulating the Expression of TMEFF1
PURPOSE: An important issue with compounds for treating ovarian cancer is the development of drug resistance and side effects. Butorphanol is a synthetic opioid. Opioids have been shown to promote or prevent tumor growth and metastasis. This research aimed to reveal the affection of Butorphanol on t...
Autores principales: | Wang, Baosheng, Li, Yuwen, Shen, Yangyang, Xu, Yong, Zhang, Chuanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604863/ https://www.ncbi.nlm.nih.gov/pubmed/33149612 http://dx.doi.org/10.2147/OTT.S244928 |
Ejemplares similares
-
Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)
por: Zhang, Chuanfeng, et al.
Publicado: (2019) -
TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2019) -
Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells
por: Nie, Xin, et al.
Publicado: (2021) -
CircTmeff1 Promotes Muscle Atrophy by Interacting with TDP‐43 and Encoding A Novel TMEFF1‐339aa Protein
por: Chen, Rui, et al.
Publicado: (2023) -
Expression of TMEFF2 in Human Pancreatic Cancer Tissue and the Effects of TMEFF2 Knockdown on Cell, Proliferation, and Apoptosis in Human Pancreatic Cell Lines
por: Li, Kailiang, et al.
Publicado: (2019)